Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1983 1
1984 2
1985 2
1986 4
1987 8
1988 6
1989 7
1990 1
1991 6
1992 5
1993 3
1994 8
1995 4
1996 7
1997 5
1998 8
1999 11
2000 18
2001 12
2002 9
2003 6
2004 11
2005 13
2006 9
2007 8
2008 8
2009 2
2010 5
2011 9
2012 8
2013 4
2014 12
2015 2
2016 7
2017 7
2018 8
2019 6
2020 10
2021 5
2022 14
2023 9
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

287 results

Results by year

Filters applied: . Clear all
Page 1
The side-effects of ciclosporine-A and tacrolimus.
Mihatsch MJ, Kyo M, Morozumi K, Yamaguchi Y, Nickeleit V, Ryffel B. Mihatsch MJ, et al. Among authors: morozumi k. Clin Nephrol. 1998 Jun;49(6):356-63. Clin Nephrol. 1998. PMID: 9696431 Review.
The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database.
Koguchi T, Naito S, Hatakeyama S, Numakura K, Muto Y, Kato R, Kojima T, Kawasaki Y, Morozumi K, Kandori S, Kawamura S, Nishiyama H, Ito A, Habuchi T, Obara W, Ohyama C, Tsuchiya N, Kojima Y. Koguchi T, et al. Among authors: morozumi k. Cancer Med. 2023 Nov;12(22):20677-20689. doi: 10.1002/cam4.6591. Epub 2023 Oct 31. Cancer Med. 2023. PMID: 37905674 Free PMC article.
Evaluating a CTSA-funded pilot grant program.
Morozumi K, Patel T, Kerr P, Cassely MB, Carey T, Buse J, Carnegie A, Egan T, Dave G. Morozumi K, et al. J Clin Transl Sci. 2020 Nov 16;5(1):e63. doi: 10.1017/cts.2020.557. J Clin Transl Sci. 2020. PMID: 33948283 Free PMC article.
Current problems of chronic active antibody-mediated rejection.
Takeda A, Horike K, Ohtsuka Y, Inaguma D, Goto N, Watarai Y, Uchida K, Morozumi K. Takeda A, et al. Among authors: morozumi k. Clin Transplant. 2011 Jul;25 Suppl 23:2-5. doi: 10.1111/j.1399-0012.2011.01451.x. Clin Transplant. 2011. PMID: 21623906 Review.
Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease.
Okada E, Morisada N, Horinouchi T, Fujii H, Tsuji T, Miura M, Katori H, Kitagawa M, Morozumi K, Toriyama T, Nakamura Y, Nishikomori R, Nagai S, Kondo A, Aoto Y, Ishiko S, Rossanti R, Sakakibara N, Nagano C, Yamamura T, Ishimori S, Usui J, Yamagata K, Iijima K, Imasawa T, Nozu K. Okada E, et al. Among authors: morozumi k. Kidney Int Rep. 2022 Jan 4;7(4):857-866. doi: 10.1016/j.ekir.2021.12.037. eCollection 2022 Apr. Kidney Int Rep. 2022. PMID: 35497811 Free PMC article.
[Lupus anticoagulant].
Yoshida A, Morozumi K. Yoshida A, et al. Among authors: morozumi k. Rinsho Byori. 1992 Oct;40(10):1007-13. Rinsho Byori. 1992. PMID: 1307602 Review. Japanese.
Acute Kidney Injury and Remission of Proteinuria in Minimal Change Disease.
Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Takeda A, Uchida S, Tsukamoto T, Tsuruya K, Akai Y, Nitta K, Fukunaga M, Hayashi H, Shoji T, Masutani K, Konta T, Katafuchi R, Nishio S, Wada T, Goto S, Tamai H, Shirasaki A, Nagai K, Nishino T, Yamagata K, Kazama JJ, Hiromura K, Yasuda H, Sofue T, Fujimoto S, Mizutani M, Naruse T, Hiramatsu T, Morozumi K, Sobajima H, Saka Y, Ishimura E, Ito T, Ichikawa D, Shigematsu T, Sato H, Narita I, Yoshitaka I; Japan Nephrotic Syndrome Cohort Study investigators. Yamamoto R, et al. Among authors: morozumi k. Kidney Int Rep. 2022 Aug 5;7(10):2283-2288. doi: 10.1016/j.ekir.2022.07.173. eCollection 2022 Oct. Kidney Int Rep. 2022. PMID: 36217532 Free PMC article. No abstract available.
Initiation of renin-angiotensin system inhibitors and first complete remission in patients with primary nephrotic syndrome: a nationwide cohort study.
Shimizu S, Niihata K, Nishiwaki H, Shibagaki Y, Yamamoto R, Nitta K, Tsukamoto T, Uchida S, Takeda A, Okada H, Narita I, Isaka Y, Kurita N; Japan Nephrotic Syndrome Cohort Study Group. Shimizu S, et al. Clin Exp Nephrol. 2023 May;27(5):480-489. doi: 10.1007/s10157-023-02331-3. Epub 2023 Feb 25. Clin Exp Nephrol. 2023. PMID: 36840902
287 results